Genetic origins and proteomic consequences of kinetoplast loss in trypanosomes
Melanie Ridgway, Douglas O. Escrivani, Markéta Novotná, Amy Wood, Michele Tinti, Achim Schnaufer, David Horn, Cynthia He, Cynthia He, Cynthia He

TL;DR
This study explores how mutations in a key mitochondrial protein in African trypanosomes lead to loss of the large mitochondrial genome and drug resistance.
Contribution
The paper introduces a method to precisely edit the gamma subunit of ATP synthase and identifies novel mutations associated with kinetoplast DNA loss.
Findings
Homozygous M282F γATPase mutants become resistant to kDNA-targeting drugs.
kDNA loss is accompanied by specific depletion of mitochondrial RNA-processing factors and kDNA-binding proteins.
Mitochondrial membrane-associated transporters increase in abundance after kDNA loss.
Abstract
The kinetoplast incorporates the large mitochondrial genome present in the eponymous Kinetoplastida. Trypanosoma brucei is an African trypanosome that can lose kinetoplast DNA (kDNA), however, when the nuclear-encoded gamma subunit of the mitochondrial F1FO-ATP synthase (γATPase) is mutated. These mutations, analogous to a broken camshaft at the core of the ATP synthase rotary motor, are associated with multidrug resistance, and correlated with tsetse-fly independent mechanical transmission, and geographical spread of these parasites beyond Africa. Here we engineer kDNA-independent T. brucei to explore origins and consequences of kDNA loss. We use oligo targeting to edit the native γATPase gene, and selection with the ATP synthase targeting drug oligomycin to enrich the desired mutants. Using this approach, we identify novel M282F, M282W, and M282Y mutants, and subsequently generate…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Fig 1
Fig 2
Fig 3
Fig 4
Fig 5
Fig 6- —http://dx.doi.org/10.13039/100010269Wellcome Trust
- —http://dx.doi.org/10.13039/100010269Wellcome Trust
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsTrypanosoma species research and implications · ATP Synthase and ATPases Research · Mitochondrial Function and Pathology
Introduction
Trypanosoma brucei brucei is an African trypanosome that is transmitted by tsetse flies, causing nagana disease in cattle and other livestock. Closely related and similarly transmitted African trypanosomes cause sleeping sickness in humans*.* These parasites are kinetoplastids, flagellated protozoa that contain their mitochondrial genome (mtDNA) in a kinetoplast, hence called kinetoplast DNA, or kDNA. The kDNA is a cytologically prominent feature and comprises a huge network of approximately twenty-five maxicircles and thousands of minicircles, encoding eighteen protein subunits of the mitochondrial respiratory chain, the F_1_F_O_-ATP synthase and the mitoribosome, as well as ribosomal RNA and RNA-editing associated guide RNAs [1,2]. Insect stage T. brucei depend on kDNA-encoded proteins for oxidative phosphorylation, while the bloodstream stage requires F_1_F_O_-ATPase activity to generate the mitochondrial membrane potential; whereby ATP hydrolysis by F_1_ is coupled to proton transfer by F_O_ [3]. Key to this coupling is the central F_1_ γ subunit (γATPase), which acts like a camshaft. γATPase is mechanically coupled to the membrane embedded ring composed of 10 c subunits that, together with the A6 subunit (also known as the a subunit), forms the proton translocating part of F_O_ [4,5]. A6 is the only F_1_F_O_-ATPase subunit encoded in kDNA. Because of its essentiality to African trypanosomes and its unique properties, kDNA has proven to be an excellent drug target, albeit with challenges associated with resistance [6,7].
Remarkably, African trypanosomes of the T. brucei group can lose their kDNA, and T. b. equiperdum and T. b. evansi, first identified in the 1800’s, present two examples [8,9]. These parasites still infect equids and various mammals, respectively, and grow as bloodstream forms [7] but cannot differentiate to tsetse insect stages [10]. Although unable to complete the usual life cycle in tsetse, they are transmitted mechanically, either sexually in equids (equiperdum), or by biting flies or vampire bats (evansi). Consequently, T. b. equiperdum and T. b. evansi cause diseases known as dourine and surra, respectively, that have spread beyond tsetse endemic regions in Africa, extending to Asia, South America and parts of Europe [11].
kDNA dispensability is caused by specific mutations in γATPase, by allowing for generation of a mitochondrial membrane potential, albeit potentially reduced, in the absence of the kDNA-encoded F_O_ subunit A6 [12–14]. This is thought to involve mechanical uncoupling of the F_1_ and F_O_ components, enhanced ATP hydrolysis by F_1_ and electrogenic exchange of mitochondrial ADP^3-^ for cytosolic ATP^4-^ by the mitochondrial ADP/ATP carrier [15]. Remarkably, beyond the A6 subunit, and the mitoribosome subunits required for its translation, no other kDNA-encoded protein appears to be specifically required to maintain the viability of wild-type bloodstream-form T. b. brucei. Trypanosomes with γATPase mutations have emerged several times independently, being equivalent to mutations that enable mtDNA loss in petite-negative yeast [8,14,15]. These parasites are either dyskinetoplastic or akinetoplastic, lacking some or all of their kDNA, respectively. Other subsequent changes appear to have facilitated adaptation to a tsetse fly independent life-cycle [9].
The kDNA has proven to be an excellent drug target, and several veterinary anti-trypanosomal drugs target kDNA, including ethidium bromide and isometamidium. kDNA loss or dispensability in T. b. evansi, T. b. equiperdum, and other γATPase mutants renders these cells multidrug resistant, however [7]. Despite connections to the parasite life cycle, geographical disease distribution, and drug resistance, the mechanisms linking γATPase mutations to kDNA dispensability are not fully understood. To develop our understanding of the origins and consequences of kDNA loss in trypanosomes, we used oligo-targeting [16] and engineered kDNA-independent kinetoplastids. We introduced novel and known mutations in the native γATPase gene and found that a novel homozygous M^282^F edit rendered the kDNA dispensable. We then used proteomics analysis to assess the complement of proteins impacted by γATPase mutation pre and post kDNA loss, revealing specific impacts on the mitochondrial ATP synthase, mitochondrial nucleic acid binding proteins and mitochondrial membrane-associated transporters.
Results
γATPase editing yielded known and novel oligomycin-resistant mutants
Three distinct non-synonymous substitutions have been identified in the γATPase subunit in trypanosomes that display kDNA dispensability; L^262^P, A^273^P, and M^282^L [12–14]. A^273^P was identified as a homozygous single-nucleotide mutation in T. b. equiperdum, M^282^L was identified as a heterozygous single-nucleotide mutation in some isolates of T. b. evansi [14], and L^262^P was later identified as a homozygous single-nucleotide mutation in T. b. brucei following acriflavine-selection in the laboratory [12]. The link to kDNA dispensability was validated for both the L^262^P and A^273^P mutations using ectopic γATPase expression in transgenic T. b. brucei, but a similar assay failed to validate the M^282^L mutation [12].
To assess the impact of specific mutations at the native γATPase gene locus (Tb927.10.180) in T. b. brucei, we used oligo targeting for precision editing [16], followed by oligomycin selection to enrich those mutants that become independent of the F_O_ component of the ATPase (Fig 1A); oligomycin targets the proton-binding F_O_ subunit c [17]. Given uncertainty regarding the impact of the M^282^L mutation, we began by assessing edits at this site. For oligo targeting, we typically deliver approximately 50 base ‘reverse-strand’ single-stranded oligodeoxynucleotides (ssODNs) by electroporation, and in this case, we designed a 53-b ssODN to target the M^282^ site with a centrally located and degenerate ‘NNN’ (N = A, C, T, G) codon (Sheet 1 in S1 Data). Wild type T. b. brucei cells were transfected in duplicate and grown with oligomycin at 200 nM; approximately three times the EC_50_ (Effective Concentration of drug to inhibit growth by 50%). We then extracted genomic DNA from surviving cells after six days, PCR-amplified the edited region in the γATPase gene, deep-sequenced the γATPase amplicons (Fig 1A), and quantified variant codons. The heatmap in Fig 1B shows relative representation of alternative codons at the targeted site and at flanking sites following oligomycin selection. The analysis revealed highly specific editing at the targeted site, and multiple M^282^ γATPase edits enriched in the oligomycin-resistant population, all of which encode aromatic residues, M^282^F, M^282^W, and M^282^Y (Fig 1B). Notably, all of the enriched mutants required double or triple nucleotide edits while the naturally occurring M^282^L mutation of uncertain significance, accessible via two distinct single nucleotide edits, or four distinct double nucleotide edits, was not enriched.
γATPase editing yielded known and novel oligomycin-resistantmutants.(A) The schematic illustrates oligo targeting for saturation mutagenesis of the T. b. brucei γATPase M282 residue. A sixty-four fold degenerate ssODN was transfected into wild-type T. b. brucei cells, followed by oligomycin selection and γATPase amplicon-sequencing. (B) The heat map shows relative representation of each possible amino acid variant at the targeted M282 site and at adjacent sites; averages for two independent oligomycin-resistant cultures relative to an unedited control. More than 8 M reads were mapped per site on average. Unedited codons are indicated (black) as is the previously reported M282L mutation (red outline). (C) The Sanger sequencing traces show single allele edits encoding the L262P, A273P and M282F mutations, each involving a double nucleotide edit; edited nucleotides are indicated by asterisks. (D) Simplified schematic of the trypanosome F1FO-ATP synthase and key components discussed here. Names of F1 subunits are in white letters (F1 subunits p18, delta and epsilon were omitted for simplicity). The α/β hexamer (cyan) is held in place by attachment to the peripheral ‘stator’ stalk (green) via the OSCP subunit (orange). The proton-translocating part consists of the c10-ring (grey) and the kDNA-encoded A6 subunit (red). PMS, peripheral membrane subcomplex (blue); IMM, inner mitochondrial membrane. The AlphaFold models for wild-type (WT) and mutant γATPase were generated using the AlphaFold server, showing mutant residues in green.
We next designed specific ssODNs to introduce one of the novel edits identified above, M^282^F^TTT^, or the other non-synonymous substitutions previously linked to kDNA dispensability, L^262^P^CCA^ and A^273^P^CCC^ (Fig 1C, Sheet 1 in S1 Data); a double nucleotide edit in each case allowed us to distinguish between true edits and spontaneous mutations, the vast majority of which are limited to single nucleotides. We transfected wild type T. b. brucei cells with each ssODN, selected the cells with oligomycin at 200 nM, and sub-cloned the resistant cells that emerged. We extracted genomic DNA from the sub-clones, PCR-amplified the edited region in the γATPase gene, and Sanger sequenced the amplicons. Sequencing analysis revealed that all three heterozygous edits were effectively introduced (Fig 1C). We then used AlphaFold [18] to visualise how these edits may impact γ-subunit function. The F_1_ component of the ATP synthase comprises a rotor made up of three α-subunits and three β-subunits with a central γ-subunit, which is analogous to a camshaft (Fig 1D). The models predict conformational defects associated with each γATPase mutation, in the extended α-helical camshaft-like segment, and more clearly apparent in the A^273^P mutant. These mutations may interfere with interaction with the α/β hexamer, perhaps uncoupling F_1_ from F_O_ as described for mitochondrial genome integrity mutations in yeast [19], thereby also reducing sensitivity to the F_O_ inhibitor oligomycin. Thus, γATPase precision editing yielded known and novel heterozygous oligomycin-resistant mutants.
Only bi-allelic M282F γATPase editing yielded acriflavine-resistant mutants
Prior analyses suggested that γATPase mutant dosage may be important. Specifically, a heterozygous A^281^Δ mutant γATPase allele was reported to be preferentially expressed in T. b. evansi [14], while both L^262^P and A^273^P γATPase substitutions with a validated link to kDNA dispensability are present as homozygous mutations in T. b. brucei [12] and T. b. equiperdum [14], respectively. Since differential expression of mutant alleles could impact the behaviour of heterozygous mutants, we favoured the analysis of homozygous mutants. Although we had not previously observed homozygous editing using oligo targeting, we identified a homozygous γATPase M^282^F^TTT^ edited clone following oligomycin selection as detailed above. Indeed, a synonymous polymorphism present seven codons downstream of the targeted codon allowed us to show that both heterozygous and homozygous M^282^F^TTT^ strains remained diploid at this locus, having retained both γATPase alleles (Fig 2A). Since oligomycin, used above to enrich for edited cells, targets the F_O_ subunit of the ATPase rather than kDNA, we determined whether the edited mutants retained kDNA. Indeed, more than 99% of heterozygous L^262^P and A^273^P mutant cells and homozygous M^282^F mutant cells remained kDNA positive as assessed by DNA-staining and microscopy.
Only bi-allelic γATPase M282 editing yielded acriflavine-resistant mutants.(A) The Sanger sequencing traces show T. b. brucei γATPase M282F edits, both heterozygous and homozygous. A GCT/G, alanine polymorphism can be seen on the right-hand side of each panel, confirming retention of both alleles. Edited nucleotides are indicated by asterisks. (B) Dose-response curves for oligomycin, measured in duplicate. EC50 values are shown. (C) Dose-response curves for acriflavine, measured in duplicate. EC50 values are shown.
Access to both heterozygous and homozygous M^282^F^TTT^ strains presented an opportunity to compare impacts on oligomycin sensitivity. We performed dose response assays comparing wild-type, heterozygous and homozygous mutants. An oligomycin dose response assay revealed that heterozygous M^282^F^TTT^ parasites displayed 3-fold increased EC_50_ while homozygous M^282^F^TTT^ mutant parasites displayed 10-fold increased EC_50_ (Fig 2B); the heterozygous L^262^P and A^273^P mutants displayed 8-fold and 22-fold increased EC_50_, respectively (S1 Fig). Thus, all of the γATPase edits yielded significant increases in oligomycin resistance (P < 1e^-4^), as expected, but the dosage of mutant γATPase alleles in the M^282^F^TTT^ edited cells impacted the relative shift in EC_50_.
We next performed dose response assays using acriflavine, a DNA-intercalating agent that targets kDNA, again comparing wild-type, heterozygous and homozygous mutants (Fig 2C). We observed that homozygous M^282^F^TTT^ parasites displayed a significant, 3-fold increased EC_50_ (P < 1e^-4^), while heterozygous M^282^F^TTT^ parasites displayed only 1.1-fold (P = 0.4) increase in EC_50_ (Fig 2C); the heterozygous L^262^P and A^273^P mutants both displayed 2-fold and 2.2-fold increased EC_50_ respectively (S1 Fig). Thus, homozygous M^282^F^TTT^ edits yielded acriflavine resistant cells, while heterozygous edits failed to do so, indicating that this mutation is recessive with respect to acriflavine-resistance. We concluded that both heterozygous and homozygous γATPase M^282^F^TTT^ editing conferred oligomycin-resistance, albeit to differing degrees, while only homozygous γATPase M^282^F^TTT^ editing conferred acriflavine-resistance.
ATP synthase remodelling and kDNA loss in homozygous γATPase mutants
To further elucidate the mechanism underpinning oligomycin and acriflavine cross-resistance, wild-type and homozygous γATPase M^282^F^TTT^ edited parasites were assessed using high resolution quantitative proteomics on an Orbitrap Astral mass spectrometer with data-independent acquisition (Sheet 2 in S1 Data). The analysis revealed highly specific depletion of all eighteen known nuclear-encoded subunits of the F_O_ component of the T. b. brucei ATP synthase (Fig 3, see Fig 1D); the peripheral stalk proteins, including the oligomycin sensitivity conferring protein OSCP, membrane region proteins and peripheral membrane subcomplex proteins [5]. In striking contrast, subunits of the F_1_ component of the ATP synthase, including the mutated γ subunit itself, were not depleted (Fig 3A). Thus, proteomic analysis revealed highly specific depletion of subunits of the F_O_ component of the T. b. brucei ATP synthase in homozygous M^282^F^TTT^ mutants. To determine whether depletion of F_O_ subunits had major impacts on kDNA or on mitochondrial membrane potential, we examined both wild-type cells and homozygous M^282^F^TTT^ mutants by microscopy following DNA-staining, and by flow cytometry following MitoTracker staining. More than 99% of these cells were kDNA positive by microscopy (Fig 3B), and MitoTracker staining appeared unperturbed when assessed using flow cytometry (Fig 3C).
ATP synthase remodelling in homozygousγATPase mutants.(A) Proteomics analysis of wild-type T. b. brucei and homozygous γATPase M282F mutants. Subunits of the F1 and Fo γATPase components are highlighted. Averages from three replicates; n = 6847 proteins. (B) The microscopy images show nuclei (larger structures) and kDNA (smaller structures) in wild-type T. b. brucei and homozygous γATPase M282F mutant cells; DNA was stained with DAPI. Scale bars, 5 μm. (C) Flow cytometry analysis of MitoTracker-stained cells, wild-type and homozygous γATPase M282F mutants. The data are representative of three technical replicates. Control, unstained cells.
Since acriflavine inhibits kDNA replication and segregation, acriflavine resistance displayed by homozygous γATPase M^282^F^TTT^ edited parasites suggested that kDNA would be dispensable in these cells. To induce kDNA loss, we grew two parallel cultures of homozygous M^282^F^TTT^ edited cells in the presence of a sub-EC_50_ dose of acriflavine for 7 days (1.25 nM; the EC_50_ is 2 nM, see Fig 2C), which yielded populations containing approximately 50% kDNA negative cells, as determined by DNA-staining and microscopy. Each population was then cloned by limiting dilution in the absence of acriflavine and, when sufficient cells were available after 7–8 days, clones were assessed by DNA-staining and microscopy. Clones that appeared to lack kDNA, two from each independent culture, were selected for further analysis (see Fig 4A). Notably, kDNA negative M^282^F^TTT^ cells displayed a growth defect relative to the kDNA positive parent, with doubling time increased by approximately 1.5-fold to 9.4 h + /-1.5 h (n = 4); parent doubling time was 6.4 h.
kDNA loss in homozygous γATPasemutants.(A) The microscopy images show homozygous γATPase M282F mutant cells with or without kDNA, the smaller blue DNA-stained structures. DNA was stained with DAPI. Scale bars, 5 μm. (B-C) Whole genome sequencing data for wild-type (WT) T. b. brucei, the homozygous γATPase M282F mutant with kDNA (P for parent) and independently generated clones lacking kDNA. (B) The upper circular plot shows genome sequencing data mapped to the T. b. brucei nuclear chromosomes 1–11 (grey). The lower circular plot shows genome sequencing data mapped to the T. b. brucei kDNA (magenta), maxicircle sequence and the most abundant minicircle sequences; the numbers indicate minicircle ID. Mapping is for 150-bp bins and for two independently generated kDNA negative clones. (C) The heatmap shows data for maxicircle sequence, additional minicircle sequences (n = 90), and for all four kDNA negative clones. kDNA negative clone numbers are indicated in each panel.
We next considered a more sensitive approach to determine whether kDNA had been completely lost, and subjected wild-type cells, kDNA positive M^282^F^TTT^ edited cells, and all four kDNA negative clones, to whole genome sequencing. We used a recent T. b. brucei maxicircle and minicircle DNA assembly for the same strain used in our study [2] as a template for this analysis and observed highly specific loss of both classes of kDNA in independently generated kDNA negative clones without apparent changes in the nuclear genome (Fig 4B). Closer inspection of minicircle abundance indicated that some were already depleted in M^282^F^TTT^ edited cells prior to acriflavine exposure, with some of the lower abundance minicircles apparently lost entirely (Fig 4C) Thus, genome sequencing revealed some minicircle loss in homozygous M^282^F^TTT^ mutants pre acriflavine-exposure, and complete elimination of kDNA induced by acriflavine in these cells.
Mitochondrial proteome remodelling following kDNA loss
To explore the consequences of kDNA loss, we again used high resolution quantitative proteomics to compare homozygous γATPase M^282^F^TTT^ mutants with or without kDNA. Analysis of these proteomes (Sheets 3–6 in S1 Data) revealed substantial changes, including further specific depletion of subunits of the F_O_ component of the T. b. brucei ATP synthase, except for subunit c, which displayed increased abundance. As above (Fig 3A), subunits of the F_1_ component of the ATP synthase, including the mutated γ subunit itself, were not depleted (Fig 5A, S2 Fig). DNA and MitoTracker staining followed by super resolution microscopy confirmed complete loss of kDNA in the M^282^F^TTT^ mutants following acriflavine treatment and revealed broadly maintained mitochondrial structure (Fig 5B, S3 Fig). We also assessed these MitoTracker stained cells by flow cytometry, which suggested that mitochondrial membrane potential was maintained following kDNA loss (Fig 5C).
Proteomic and mitochondrial impacts of kDNA loss.(A) Proteomics analysis of homozygous γATPase M282F mutants with and without kDNA with subunits of the F1 and Fo γATPase components highlighted. Averages from three replicates; n = 6768 proteins; clone 1.2 is shown here and three other clones are shown in Supplementary Fig 2. (B) The representative super resolution microscopy images show wild-type T. b. brucei and homozygous γATPase M282F mutant cells lacking kDNA, following growth in acriflavine. DNA was stained with DAPI (cyan) and mitochondria were stained with MitoTracker (yellow). Nuclear DNA (N) and kDNA (K) are indicated. Scale bars, 2 μm. A gallery of additional images is shown in Supplementary Fig 3. (C) Flow cytometry analysis of MitoTracker-stained cells, homozygous γATPase M282F mutants with or without kDNA. Data are shown for two independent biological replicates without kDNA and are representative of three technical replicates in each case.
We next examined changes in the abundance of nuclear and mitochondrial proteins following kDNA loss and found that mitochondrial proteins were selectively and significantly reduced in abundance in all four kDNA negative clones (Fig 6A). More proteins reported a highly significant (-log_10_ False Discovery Rate [FDR] >4) reduction in abundance relative to proteins that reported increased abundance following kDNA loss (168 v 51), and a closer inspection of >2-fold depleted proteins revealed kDNA-binding proteins and mitochondrial RNA-processing factors (Fig 6B), consistent with destabilisation of these proteins after loss of all mitochondrial DNA and RNA. These included the kDNA-associated proteins involved in DNA compaction [20], and kDNA anchoring to the tripartite attachment complex [21], primases [22], polymerases [23], topoisomerase involved in DNA replication, and mRNA polyadenylation factors [24]. Other depleted proteins were the calcium uniporter, known to interact with subunit c of the ATP-synthase [25], and PUF9, an RNA-binding protein involved in nuclear cell cycle regulation [26]. Notably, IF1, an inhibitor of F_1_-mediated ATP hydrolysis, was also depleted. Expression of this protein was thought to be restricted to the insect stage, where ATP synthesis, but not hydrolysis, is essential [27]. This observation might indicate increased ATP hydrolysis following kDNA loss. In contrast, PUF9 target 1 (PNT1), a kDNA replication-associated peptidase [28], is notably increased in abundance in kDNA negative cells (Fig 6B).
Mitochondrial proteome remodelling following kDNA loss.(A) Proteomics analysis of homozygous γATPase M282F T. b. brucei mutants and all four M282F clones lacking kDNA. The boxplot shows nuclear proteins (n = 1185, GO:0005634) and mitochondrial proteins (n = 1431, GO:0005739). Boxes indicate the interquartile range (IQR) and the whiskers show the range of values within 1.5 × IQR. (B) Proteomics analysis showing all proteins with log2 average expression >16 and with some notable proteins highlighted. (C) Gene Ontology profiles for proteins with log2 average expression >16 that are significantly (>2 –log10 FDR) decreased or increased in abundance in kDNA negative cells. Mito’, mitochondrial. (D) Selected cohorts of proteins that are significantly decreased or increased in abundance in kDNA negative cells. Boxes indicate the interquartile range (IQR) and the whiskers show the range of values within 1.5 × IQR. MCP, mitochondrial carrier proteins; TIM, Translocases of the Inner Membrane; ATOM, Archaic Translocase of the Outer Membrane; MICOS, Mitochondrial contact site and Cristae Organizing System; POMP, Present in the Outer mitochondrial Membrane Proteome; EMC, ER-Membrane Complex; ER, Endoplasmic Reticulum. Cohorts were derived using GO-terms except for kinetoplast-associated proteins from [31] and MCP, TIM and POMP, derived using wild-card searches, MCP, TIM* and POMP* at https://tritrypdb.org [43]. Data are shown for kDNA negative clones 1.2 (blue) and 2.1 (red).*
Finally, we profiled proteins that were significantly (FDR < 0.01) reduced (n = 507) or increased (n = 761) in abundance following kDNA loss (Sheets 3–6 in S1 Data), using Gene Ontology (GO) terms. The top GO-term hits for depleted proteins were exclusively associated with the mitochondrion, again including DNA and RNA binding proteins, and ATP synthase (Fig 6C, upper panel). Kinetoplast (P = 1.4e^-89^) and mitochondrial matrix (P = 4.1e^-148^) registered the highest significance, and components of the NADH dehydrogenase, complex I of the electron transport chain, were also significantly depleted; perhaps unsurprisingly since several components of this complex are encoded in kDNA [1,2]. In contrast, mitochondrial membrane-associated transporters, and endoplasmic reticulum (ER) associated proteins, were significantly increased in abundance (Fig 6C, lower panel). The telomere-telomerase complex and nuclear pore proteins were also increased, perhaps reflecting connections between nuclear and kDNA replication [29]. Changes in abundance for several of these cohorts of proteins are shown in Fig 6D, revealing substantial depletion of the mitochondrial ribosome, RNA editing complex [30] and kinetoplast-associated proteins [31]. The tripartite attachment complex itself [21] is notably not substantially depleted, and only the p166 component (Tb927.11.3290) achieved an FDR < 0.01 following kDNA loss (log_2_ fold-change = -0.52 + /-0.12); indeed, kDNA is not required for assembly of this complex [32]. The mitochondrial carrier proteins [33], translocase of the inner mitochondrial membrane (TIM) [34], archaic translocase of the outer mitochondrial membrane (ATOM), and mitochondrial contact site and cristae organization system [35], were all increased in abundance (Fig 6D), perhaps compensating for defects in mitochondrial import and supporting the maintenance of mitochondrial membrane potential [13,36]. Proteins present in the outer mitochondrial membrane proteome (POMP), many of which remain otherwise uncharacterised [37], were also increased in abundance. Finally, the ER-membrane complex (EMC), previously connected to kDNA dependency [6], and now known to localise to the mitochondrial – ER interface [38], was increased in abundance (Fig 6D). Taken together, our results reveal ATP synthase complex remodelling associated with bi-allelic γATPase mutation and resistance to both ATPase and kDNA-targeting drugs; oligomycin and acriflavine, respectively. These cells readily tolerate kDNA loss, which is associated with substantial mitochondrial proteome remodelling.
Discussion
γATPase mutations in T. brucei are associated with kDNA loss and multidrug resistance and are also correlated with tsetse-fly independent mechanical transmission and geographical spread of these parasites beyond Africa. Here, we explore γATPase mutations and connections to kDNA loss in T. b. brucei. We precision-edited the native γATPase gene, confirming that L^262^P and A^273^P mutants are resistant to the ATP synthase targeting drug oligomycin and to the kDNA-targeting drug, acriflavine. We also identified novel oligomycin-resistant aromatic amino-acid mutants replacing M^282^. Quantitative proteomics analysis of homozygous M^282^ mutants revealed specific depletion of ATP synthase F_O_ components prior to kDNA loss. Following acriflavine-induced kDNA loss, confirmed to be complete by genome sequencing, we observed substantial mitochondrial proteome remodelling; the abundance of mitochondrial DNA and mRNA binding proteins was reduced while the abundance of proteins involved in mitochondrial import was increased. While we observed further depletion of ATP synthase F_O_ components following kDNA loss, c subunit abundance was increased, perhaps reflecting accumulation of F_1_-ATP synthase associated with only the c-ring of the F_O_ moiety (see Fig 1D).
In terms of the origins of kDNA loss, we found that precision-editing could be used to generate both heterozygous and homozygous γATPase mutants in otherwise wild-type trypanosomes. While a heterozygous M^282^F edit failed to confer resistance to acriflavine, a homozygous M^282^F mutant was acriflavine-resistant and readily tolerated kDNA loss. We used quantitative proteomics to explore the impact of the homozygous M^282^F edit prior to kDNA loss and observed highly specific depletion of ATP synthase-associated proteins; possibly due to increased turnover when unassembled. Importantly, we selected for edited cells using oligomycin rather than a DNA-damaging agent, avoiding direct selective pressure on the kDNA and likely reducing the potential for off-target mutations at this stage of the process. It is also worth noting in this regard that the widespread use of veterinary anti-trypanosomal drugs that target the kDNA, such as the DNA-damaging agents, ethidium bromide and isometamidium, could induce γATPase mutations and/or other mutations, and promote kDNA loss in the field [39].
A homozygous M^282^F γATPase edit generated here in T. b. brucei was sufficient to confer kDNA dispensability*,* while a heterozygous edit was insufficient. This recessive effect with respect to kDNA dispensability suggested a dosage effect and prompted further consideration of naturally occurring non-synonymous γATPase mutations implicated in conferring kDNA dispensability; a heterozygous M^282^L mutation in some isolates of T. b. evansi [14], a homozygous A^273^P mutation in T. b. equiperdum [14], and a homozygous L^262^P mutation in T. b. brucei [12]. Among these non-synonymous edits, we only failed to recover M^282^L using oligomycin selection. Indeed, ectopic mutant γATPase expression assays in T. b. brucei also indicated that the M^282^L mutation is insufficient to confer kDNA dispensability [12]. On the other hand, ectopic expression assays suggested that a single A^273^P or L^262^P allele may be sufficient to confer kDNA dispensability, and our demonstration that heterozygous A^273^P or L^262^P edits are sufficient to confer acriflavine resistance is consistent with this view. Homozygous editing described here is the first example of dual-allele oligo targeting, suggesting that this approach may be exploited to generate and assess further homozygous γATPase mutants.
We also used quantitative proteomics to elucidate the consequences of kDNA loss in homozygous M^282^F γATPase mutants and observed extensive proteome remodelling in this case. Perhaps unsurprisingly, kDNA-binding proteins and mitochondrial RNA-processing factors were significantly depleted in the absence of mitochondrial DNA and RNA; residual editing complexes in kDNA-negative cells have been reported to retain function, however [40]. Mitochondrial membrane-associated transporters on the other hand were significantly increased in abundance, suggesting a boost in mitochondrial protein import capacity and inter-organellar trafficking capacity. Indeed, we found increased abundance of components of the ER membrane complex particularly intriguing, since we previously linked expression of this complex to kDNA dispensability in the absence of γATPase mutation [6]; this complex is now known to localise to the mitochondrial – ER interface [38]. These adaptations may compensate for mitochondrial import defects associated with changes in F_1_F_O_-ATP synthase assembly and maintenance of mitochondrial membrane potential. Similarly, these adaptations may reflect a response to depletion of other multiprotein complexes that contain kDNA-encoded proteins, such as respiratory complex I or the mitoribosome [13,36]. Proteome remodelling was not sufficient to recover a wild-type growth rate here, however, consistent with further adaptation thought to have occurred in T. b. evansi andT. b. equiperdum [9].
Notably, association of mutant F_1_ with the inner mitochondrial membrane, perhaps proximal to the ATP/ADP carrier, is thought to be required to sustain mitochondrial membrane potential following kDNA loss [15,41]. Subunit c of the ATP synthase was selectively increased in abundance following kDNA loss, and although it was suggested that subunit c interacts with the calcium uniporter [25], the uniporter was reduced in abundance. We note here that analysis by native gel electrophoresis detected putative ‘F1-c’ complexes as a major ATP synthase assembly state in dyskinetoplastic T. brucei [41]. In the ATP synthase assembly pathway elucidated for other eukaryotes, subunit a (A6 in trypanosomes) is attached to F_1_-c before assembly with the F_O_ part [42]. We therefore suggest that, in the absence of the kDNA-encoded subunit A6, ATP synthase assembly beyond F_1_-c is impaired; a hypothesis that could be tested in the future. Other adaptations may reflect disrupted communication between the kDNA and nuclear DNA. For example, PUF9 target 1, a kDNA replication-associated peptidase [28], was increased in abundance while the RNA-binding protein PUF9, involved in nuclear cell cycle regulation [26], was reduced in abundance. The telomere-telomerase complex was also increased in abundance. Taken together, these adaptations reveal a remarkable connectivity between the ATP synthase and other mitochondrial, and even other cellular, complexes and compartments.
In conclusion, T. brucei cells with a bi-allelic γATPase defect assemble a remodelled ATP synthase complex, and tolerate kDNA-loss, accompanied by substantial mitochondrial proteome remodelling. Proline mutations with the potential to disrupt helical structure at L^262^ or A^273^ in the γATPase [12,14], or bulky aromatic residue mutations at M^282^, introduce defects analogous to a broken camshaft at the core of this ATP synthase rotary motor. Our findings yield new insights into the origins and consequences of kDNA loss, with implications for the evolution of trypanosome sub-species that have global veterinary impacts.
Methods
T. brucei growth and γATPase gene editing
Bloodstream form T. b. brucei Lister 427 cells were grown in HMI-11 (Gibco) supplemented with 10% fetal bovine serum (Sigma) at 37°C and with 5% CO_2_ in a humidified incubator. For site saturation mutagenesis using oligo-targeting, a degenerate ssODN was transfected in duplicate by electroporation with a Nucleofector (Lonza), and a human T-cell kit (Lonza), with the Nucleofector set to Z-001 (Amaxa). Briefly, we used 40 µg of the ssODNs in 10 µl of 10 mM Tris-Cl, pH 8.5, mixed with 25 million cells in 100 µl transfection buffer. 200 nM oligomycin was applied 6 h after transfection. DNA was isolated 7 d later. The γATPase fragment was amplified by PCR using Q5 high fidelity DNA polymerase (New England Biolabs) as per the manufacturer’s instructions, and primers 1 and 2. Annealing was at 63^o^C and elongation was for 30 s. PCR products were purified using a Qiagen PCR purification kit. For specific mutagenesis using oligo targeting, a specific ssODN was transfected in duplicate with 10 million cells, and 200 nM oligomycin was applied 6 h after transfection. Oligomycin-resistant cultures were sub-cloned by serial dilution in 96-well plates 5 d later and DNA was extracted from the clones. The γATPase fragment was amplified by PCR as above but using primers 1 and 3 in this case. The products were Sanger sequenced using primer 4 at Azenta Life Sciences. To induce kDNA loss, cells were grown in the presence of 1.25 nM acriflavine for 7 days and then subcloned.
Dose-response assays
To determine the Effective Concentration of drug to inhibit growth by 50% (EC_50_), cells were plated in 96-well plates at 1 x 10^3^ cells/ml in a 2-fold serial dilution of selective drug. Plates were incubated at 37°C for 72 h. 20 µl resazurin sodium salt (AlamarBlue, Sigma) at 0.49 mM in PBS was then added to each well, and plates were incubated for a further 6 h. Fluorescence was determined using an Infinite 200 pro plate reader (Tecan) at an excitation wavelength of 540 nm and an emission wavelength of 590 nm. EC_50_ values were derived using Prism (GraphPad).
Mass spectrometry
Approx. 5 x 10^7^ PBS-washed cells were suspended in 100 μL of TBA (5% SDS, 100 mM triethylammonium bicarbonate); triplicate samples for each experiment and control cells. Total cell extracts were submitted to the Fingerprints Proteomics Facility at the University of Dundee and processed by trypsin: μBCA (bicinchoninic acid), strap processed, quality controlled, and peptide quantified by Micro-BCA assay (Thermo Scientific). 3 μl of each sample was processed using S-Trap Micro columns (Protifi) where proteins were reduced, alkylated and digested overnight at 37°C at 1:40 enzyme-to-substrate. A second digest was repeated for 6 h the following day. For mass spectrometry analysis, digested peptides (200 ng) were run on an Astral Orbitrap Mass Spectrometer (Thermo Scientific) coupled to a Vanquish Neo UHPLC system (Thermo Scientific). Buffer conditions used Buffer A (0.1% formic acid) and Buffer B (80% acetonitrile in 0.1% formic acid). Flow was 60 µl/min and loading volume was set at automatic. Peptides were initially trapped on a PepMap Neo C18 column (5 µm, 300 µm x 5 cm) and then separated on an Easy-Spray PepMap RSLC C18 column (2 µm, 150 µm x 15 cm) (Thermo Scientific). Columns was kept at a constant temperature of 50°C and a source voltage of 2.0 kV. Full MS scan was performed in data-independent acquisition (DIA) mode with an m/z range of 380–980 with orbitrap resolution 2400000, Automatic Gain Control (AGC) target of 500% and a maximum injection (IT) of 3 ms. MS scans were followed by MS/MS DIA using the following parameters; scans of isolation window of 2.0 m/z unit and window overlap set at 0 m/z. Normalised collision energy was set to 25%. Data for MS scans were acquired in profile mode with MS/MS DIA scan events being acquired in centroid mode.
Proteomic data analysis
We generated a spectral library based on the predicted protein sequences for T. brucei TREU927 sourced from TriTrypDB (version 51) [43]. The raw mass spectrometry data were processed using DIA-NN (version 2.2.1) [44] and analysed using default settings. Initial QC analysis, median normalisation and missing value imputation was performed with the project utility python package (https://github.com/mtinti/ProjectUtility). Differential expression analysis was performed using the limma package in R [45]. A linear model was fitted using the lmFit() function, followed by Empirical Bayes Statistics for Differential Expression computed with the ebayes() function. Adjusted p-values were calculated using the topTable function with the Benjamini & Hochberg (BH) correction method.
High-throughput sequencing
For analysis following site saturation mutagenesis, PCR amplicons were sequenced at the Beijing Genome Institute (BGI) on a DNBseq platform with 150 base paired-end reads as described previously [16] and codon-based read counts were derived using the OligoSeeker software [46]. Whole genome sequencing data were analysed with alignment to the T. b. brucei reference genome v46 clone 427_2018 supplemented with 427 maxi and minicircle sequences [2,43]. The alignment and read counts were performed with the automated snakemake [47] pipeline myRna-seq [48]. Read coverage was extracted from the BAM files using a bin size of 150 with the bamCoverage function from deepTools (v 3.5.6). The circular visualisation was performed with the pyCirclize (1.6) Python package (https://github.com/moshi4/pyCirclize).
Microscopy
To identify clones lacking kDNA, cells were fixed in 1% paraformaldehyde (PFA) for 15 min, washed twice in PBS and resuspended in water with 1% bovine serum albumin (BSA). Cells were attached to a 12-well 5 mm slide (Thermo Scientific) by drying overnight. After rehydration in PBS for 5 min, slides were mounted in Vectashield with DAPI and sealed under a coverslip. Cells were viewed at 63x magnification with oil immersion on a Zeiss Axiovert 200 M microscope with Zen Pro software (Zeiss). For mitochondria morphology visualisation, cells were stained with 100 nM Mitotracker red CMXRos (Invitrogen) for 5 min at 37°C prior to fixation in 3% PFA for 15 min, washed in PBS then resuspended in water with 1% BSA. Cells were attached to poly-lysine-coated coverslips for 4 h at room temperature then stained with DAPI for 30 min before mounting in Vectashield (without DAPI) and sealing to a glass slide. For wide-field microscopy, cells were imaged as z-stacks (0.2 μm) at 100x magnification with oil immersion on the same microscope described above. For super resolution microscopy, cells were imaged as z-stacks (0.1–0.2 μm) at 63x magnification on a Leica Stellaris 8 inverted confocal microscope equipped with Power HyD detectors and subjected to adaptive deconvolution using the integrated Leica LIGHTNING algorithm for super-resolution microscopy. Images were analysed using Fiji v1.5.2e.
MitoTracker staining and flow cytometry
Live T. brucei cells (1x10^6^/ml) were incubated with 100 nM MitoTracker Red CMXROS (Molecular Probes) at 37°C for 5 min. Cells were fixed with 1% of paraformaldehyde (PFA) at 37°C for 15 min, then washed and resuspended in cold PBS and stored at 4 °C. MitoTracker fluorescence intensity was measured using a CytoFlex S flow cytometer (Beckman Coulter) and analysed using FlowJo v10.10. Forward scatter area (FSC-A) versus forward scatter height (FSC-H) was used to exclude cell aggregates.
Supporting information
S1 FigDose-response curves. (A)For oligomycin, measured in duplicate. (B) For acriflavine, measured in duplicate.(TIF)
S2 FigProteomics analysis of homozygous γATPase M^282^F mutants with and without kDNA.Subunits of the F_1_ and F_o_ γATPase components are highlighted. Averages from three replicates; n = 6768 proteins; clone 1.2 is shown in Fig 5A.(TIF)
S3 FigGallery of super resolution microscopy images showing wild-type T. b. brucei and homozygous γATPase M^282^F mutant cells lacking kDNA.Other details as in Fig 5B.(TIF)
S1 DataOligonucleotides and proteomics data.Sheet 1: Oligonucleotides and primers used in this study. Sheet 2: Proteomics data – M^282^F kDNA positive parent v wild-type. Sheet 3: Proteomics data – M^282^F kDNA negative clone 1.1 v kDNA positive parent. Sheet 4: Proteomics data – M^282^F kDNA negative clone 1.2 v kDNA positive parent. Sheet 5: Proteomics data – M^282^F kDNA negative clone 2.1 v kDNA positive parent. Sheet 6: Proteomics data – M^282^F kDNA negative clone 2.2 v kDNA positive parent.(XLS)
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Cooper S, Wadsworth ES, Schnaufer A, Savill NJ. Organization of minicircle cassettes and guide RNA genes in Trypanosoma brucei. RNA. 2022;28(7):972–92. doi: 10.1261/rna.079022.121 35414587 PMC 9202587 · doi ↗ · pubmed ↗
- 2Zhao X, He Y, Zhang F, Aphasizheva I, Aphasizhev R, Zhang L. Comparative mitochondrial genome and transcriptome analyses reveal strain-specific features of RNA editing in Trypanosoma brucei. Nucleic Acids Res. 2025;53(13):gkaf 661. doi: 10.1093/nar/gkaf 661 40671526 PMC 12266143 · doi ↗ · pubmed ↗
- 3Zikova A. Mitochondrial adaptations throughout the Trypanosoma brucei life cycle. J Eukaryot Microbiol. 2022;69(6):e 12911. Epub 2022/03/25. doi: 10.1111/jeu.12911 35325490 · doi ↗ · pubmed ↗
- 4Gahura O, Hierro-Yap C, ZíkováA. Redesigned and reversed: architectural and functional oddities of the trypanosomal ATP synthase. Parasitology. 2021;148(10):1151–60. doi: 10.1017/S 0031182021000202 33551002 PMC 8311965 · doi ↗ · pubmed ↗
- 5Gahura O, Mühleip A, Hierro-Yap C, Panicucci B, Jain M, Hollaus D, et al. An ancestral interaction module promotes oligomerization in divergent mitochondrial ATP synthases. Nat Commun. 2022;13(1):5989. doi: 10.1038/s 41467-022-33588-z 36220811 PMC 9553925 · doi ↗ · pubmed ↗
- 6Baker N, Hamilton G, Wilkes JM, Hutchinson S, Barrett MP, Horn D. Vacuolar AT Pase depletion affects mitochondrial AT Pase function, kinetoplast dependency, and drug sensitivity in trypanosomes. Proc Natl Acad Sci U S A. 2015;112(29):9112–7. doi: 10.1073/pnas.1505411112 26150481 PMC 4517229 · doi ↗ · pubmed ↗
- 7Gould MK, Schnaufer A. Independence from Kinetoplast DNA maintenance and expression is associated with multidrug resistance in Trypanosoma brucei in vitro. Antimicrob Agents Chemother. 2014;58(5):2925–8. doi: 10.1128/AAC.00122-14 24550326 PMC 3993240 · doi ↗ · pubmed ↗
- 8Carnes J, Anupama A, Balmer O, Jackson A, Lewis M, Brown R, et al. Genome and phylogenetic analyses of Trypanosoma evansi reveal extensive similarity to T. brucei and multiple independent origins for dyskinetoplasty. P Lo S Negl Trop Dis. 2015;9(1):e 3404. doi: 10.1371/journal.pntd.0003404 25568942 PMC 4288722 · doi ↗ · pubmed ↗
